- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Prestige Biopharma Ltd (950210)
Prestige Biopharma Ltd stock price live, this page displays KS 950210 stock exchange data. View the 950210 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Prestige Biopharma Ltd real time stock price chart below.
What Is the Prestige Biopharma Ltd Stock Price Today?
The Prestige Biopharma Ltd stock price today is 15,540.
What Is the Stock Symbol for Prestige Biopharma Ltd?
The stock symbol for Prestige Biopharma Ltd is ""950210.""
What Stock Exchange Does Prestige Biopharma Ltd Trade On?
Prestige Biopharma Ltd is listed and trades on the Seoul stock exchange.
Is Prestige Biopharma Ltd a Good Stock to Buy?
Determining whether Prestige Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 950210 quote. (ISIN: KR8702070002)
What Is the Prestige Biopharma Ltd Stock Price Today?
The Prestige Biopharma Ltd stock price today is 15,540.
What Is the Stock Symbol for Prestige Biopharma Ltd?
The stock symbol for Prestige Biopharma Ltd is ""950210.""
What Stock Exchange Does Prestige Biopharma Ltd Trade On?
Prestige Biopharma Ltd is listed and trades on the Seoul stock exchange.
Is Prestige Biopharma Ltd a Good Stock to Buy?
Determining whether Prestige Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 950210 quote. (ISIN: KR8702070002)
Seoul
Currency in KRW
15,540
+1,270(+8.90%)
Delayed Data·
Fair Value
An estimate of a Prestige Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,240
15,890
52 wk Range
11,000
20,900
950210 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
950210 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Prestige Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,24015,890
52 wk Range
11,00020,900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
950210 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Prestige Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Prestige Biopharma Ltd Company Profile
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research and development and marketing of biosimilars, first-in-class antibody drugs, and vaccines. The company primarily engages in the development of biosimilars, including Trastuzumab, which is under regulatory review for breast and gastric cancer; Bevacizumab, in phase 3 clinical study for solid tumours; Adalimumab, in phase 1 clinical study for arthritis. It is developing first-in-class antibody therapeutics, such as monoclonal antibodies, bispecific antibodies, and fusion antibodies for life-threatening diseases; vaccines for COVID-19 virus; and diagnostic kits for the detection of pancreatic adenocarcinoma upregulated factor. Prestige BioPharma Limited was incorporated in 2015 and is headquartered in Singapore.
Compare 950210 to Peers and Sector
Metrics to compare | 950210 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship950210PeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.9x | −8.8x | −0.5x | |
PEG Ratio | 0.05 | −0.08 | 0.00 | |
Price/Book | 0.4x | 2.7x | 2.6x | |
Price / LTM Sales | 19.8x | 6.8x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 40.3% | |
Fair Value Upside | Unlock | 10.4% | 4.7% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
838.40 / --
Revenue / Forecast
3.34B / --
People Also Watch
FAQ
What Stock Exchange Does Prestige Biopharma Trade On?
Prestige Biopharma is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for Prestige Biopharma?
The stock symbol for Prestige Biopharma is "950210."
What Is the Prestige Biopharma Market Cap?
As of today, Prestige Biopharma market cap is 171.51B.
What Is Prestige Biopharma's Earnings Per Share (TTM)?
The Prestige Biopharma EPS (TTM) is 361.82.
From a Technical Analysis Perspective, Is 950210 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Prestige Biopharma Stock Split?
Prestige Biopharma has split 0 times.
How Many Employees Does Prestige Biopharma Have?
Prestige Biopharma has 0 employees.
What is the current trading status of Prestige Biopharma (950210)?
As of 14 Aug 2025, Prestige Biopharma (950210) is trading at a price of 15,540.00, with a previous close of 14,270.00. The stock has fluctuated within a day range of 14,240.00 to 15,890.00, while its 52-week range spans from 11,000.00 to 20,900.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.